ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
61.141,19
0,59%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Pharming Group NV Leiden (PK) (PHGUF)

  7. Pharming Group NV Leiden (PK) (PHGUF) News

PHGUF

Pharming Group NV Leiden (PK) (PHGUF)

Pharming Group NV Leiden (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PHGUF
DatumZeitQuelleÜberschriftSymbolFirma
15/12/202312h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
13/11/202315h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
25/09/202316h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
14/08/202314h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
09/08/202317h24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
18/07/202312h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
01/06/202312h15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
11/04/202314h58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
05/04/202312h57Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
27/03/202319h41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
16/03/202315h39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202312h34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202312h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
21/02/202315h43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
17/02/202316h41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
27/10/202212h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/08/202212h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/06/202214h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
18/05/202218h55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
26/04/202213h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
06/04/202222h15Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
06/04/202222h10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
06/01/202213h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
04/01/202213h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
28/10/202122h18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PHGUFPharming Group NV Leiden (PK)
28/10/202113h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
22/10/202113h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
14/09/202115h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
09/08/202122h05Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PHGUFPharming Group NV Leiden (PK)
05/08/202113h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
 Showing the most relevant articles for your search:USOTC:PHGUF

Kürzlich von Ihnen besucht

NASDAQ
AEAEU
AltEnergy Acquisition
EU
U462S
U462S
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten